Anti-Cytokine Therapy for Vasculitis

NCT00753103 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Wegener's Granulomatosis
Renal Limited Vasculitis
Microscopic Polyangiitis

Interventions

BIOLOGICAL: Infliximab
DRUG: Cyclophosphamide
DRUG: Prednisolone
DRUG: Azathioprine
PROCEDURE: Plasma exchange
DRUG: Mycophenolate mofetil
DRUG: Methylprednisolone

Sponsor

University Hospital Birmingham NHS Foundation Trust